Our latest insights

Built on world-class research and clinical trials, Australia’s biotech industry is increasingly shifting towards commercialisation, global expansion, and long-term growth.

Explore how life sciences firms can use sustainability to drive growth, resilience, and funding access.

The biotech industry faces significant challenges, including regulatory pressures, supply chain disruptions, rising costs and shifting investment landscapes.

Navigating the funding landscape can be tricky for biotech companies at all stages, from initial research and clinical trials to scaling up capabilities. Our recent roundtable discussions with over 90 Biotech CEOs, held in partnership with AusBiotech, shed light on the challenges and opportunities shaping the industry.

Biotechnology organisations often grapple with three key trends – where the next round of funding will come from, how to attract specialised talent to support vital innovation, and how to tackle manufacturing and scale up. They seek stability and certainty in funding to ensure projects are supported and reach their full potential. How can the upcoming Federal Budget announcement better support this sector?

Australia’s Biotechnology Sector Snapshot 2022, conducted by Ausbiotech and supported by Grant Thornton, has revealed an impressive 43% growth rate in the sector in the past two years.

New COVID-19 variants remain a risk for all world economies and this uncertainty has the potential to impact business confidence and investment decision-making. This will be weighing on the Australian Government as it fine-tunes the 2022-23 Federal Budget.

The 2021-2022 Federal Budget highlights new opportunities for the life sciences sector in Australia. Already a great place or research and development, it’s time we ramp up domestic commercialisation and manufacturing to better support and tap into international markets.

We’ve never been more aware of where our pharmaceuticals and medical products come from, or how long therapeutics take to go from research to product.

The Life Sciences sector has never been more important or more in the public eye.

Australia has a reputation as one of the world’s leading destinations for life sciences, developing life-changing innovations that have real social benefit – from the world’s first anti-cancer vaccine to spray-on skin for burns victims.